Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Oct 31, 2025 | (FY)Jul 31, 2025 | (Q4)Jul 31, 2025 | (Q3)Apr 30, 2025 | (Q2)Jan 31, 2025 | (Q1)Oct 31, 2024 | (FY)Jul 31, 2024 | (Q4)Jul 31, 2024 | (Q3)Apr 30, 2024 | (Q2)Jan 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 129.48%16.27K | 48.56%-143.6K | 108.52%6.5K | 48.67%-44.69K | 0.75%-50.23K | 15.51%-55.17K | -81.32%-279.18K | -9.42%-76.21K | -161.66%-87.06K | -12.08%-50.61K |
| Net income from continuing operations | 36.01%-36.93K | 26.34%-199.11K | 42.15%-38.71K | 41.39%-41.57K | 16.11%-61.13K | 3.20%-57.7K | -62.86%-270.32K | 1.89%-66.92K | -130.31%-70.92K | -44.71%-72.87K |
| Other non cashItems | --1.89K | --1.77K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Change In working capital | 1,926.11%51.3K | 706.88%53.75K | 567.45%43.44K | 80.66%-3.12K | -51.04%10.9K | 144.50%2.53K | -173.71%-8.86K | -544.01%-9.29K | -551.39%-16.14K | 328.01%22.26K |
| -Change in receivables | -40.83%-2.95K | 322.49%15.52K | 369.57%24.06K | 58.64%-1.78K | -149.18%-4.66K | 34.99%-2.09K | -204.49%-6.98K | -79.32%-8.93K | -213.76%-4.31K | -36.94%9.48K |
| -Change in prepaid assets | 360.80%2.2K | 683.52%8.25K | 92.23%-483 | 34.26%4.26K | -41.10%3.99K | 109.26%477 | 59.85%-1.41K | -182.81%-6.22K | 163.66%3.18K | 102.96%6.78K |
| -Change in payables and accrued expense | 1,154.57%52.05K | 6,506.20%29.98K | 239.50%19.86K | 62.65%-5.6K | 92.83%11.57K | 54.76%4.15K | -105.28%-468 | 2.06%5.85K | -486.00%-15K | 145.54%6K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 129.48%16.27K | 48.56%-143.6K | 108.52%6.5K | 48.67%-44.69K | 0.75%-50.23K | 15.51%-55.17K | -81.32%-279.18K | -9.42%-76.21K | -161.66%-87.06K | -12.08%-50.61K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -1,287.53%-16.36K | 95.84%-5K | 0 | -5K | 176.78%1.18K | -1.18K | -217.14%-119.94K | -27,957.35%-118.4K | 0 | 44.01%-1.54K |
| Net PPE purchase and sale | --21.85K | 188.17%102.93K | 188.33%101.74K | --0 | --1.18K | --0 | -9,627.58%-116.73K | ---115.19K | --0 | ---- |
| Net other investing changes | -3,140.88%-38.21K | -3,258.89%-107.92K | ---101.74K | ---5K | --0 | ---1.18K | 91.23%-3.21K | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -1,287.53%-16.36K | 95.84%-5K | --0 | ---5K | 176.78%1.18K | ---1.18K | -217.14%-119.94K | -27,957.35%-118.4K | --0 | 44.01%-1.54K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 50K | 0 | ||||||||
| Net issuance payments of debt | ---- | --50K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | ---- | --50K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Net cash flow | ||||||||||
| Beginning cash position | -61.32%62.2K | -71.28%160.79K | -98.39%5.71K | -87.48%55.4K | -78.88%104.44K | -71.28%160.79K | -25.51%559.91K | -43.59%355.4K | -33.41%442.46K | -30.57%494.61K |
| Current changes in cash | 99.83%-93 | 75.30%-98.59K | 129.03%56.5K | 42.92%-49.69K | 5.96%-49.05K | 13.71%-56.35K | -108.10%-399.12K | -177.75%-194.61K | -152.55%-87.06K | -8.85%-52.15K |
| End cash Position | -40.53%62.11K | -61.32%62.2K | -61.32%62.2K | -98.39%5.71K | -87.48%55.4K | -78.88%104.44K | -71.28%160.79K | -71.28%160.79K | -43.59%355.4K | -33.41%442.46K |
| Free cash from | 129.48%16.27K | 62.47%-148.6K | 100.78%1.5K | 48.67%-44.69K | 3.69%-50.23K | 15.51%-55.17K | -155.15%-395.91K | -174.82%-191.4K | -152.55%-87.06K | -15.49%-52.15K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.